@GregBeaud On te remerciera jamais assez d'avoir fait le dirty work de Dubé en publiant l'article initial du mécontentement de Wallmark avec RR. Tu t'es bien fait utilisé et Dubé a fort bien exécuté sa vengeance, avec ta généreuse complicité cela dit
@Franca_ole Sgmo is living proof that you can have the best science, but if you have a garbage management, your company is still going to fail. What a waste
@ErineEmail For me the service has not been functional since that incident. If I go in erine account, mail are marked as sent, but I don't receive them in my Gmail address anymore. Do you know that is going on?
@robin_j_brooks Considering your position, it's quite staggering how little you understand from economics. Swiss didn't front run gold, it's US demands for gold that exploded because of the whole economic uncertainty trump fosters.
@RNAiAnalyst EMA might take a couple more months but at least the outcome is somewhat predictable and based on objective criteria. Unless FDA's decisions that are no driven by the mood of some anti-science nutjob
@RNAiAnalyst I have to lol a bit on this one. Have you seen recent FDA CRLs? With Prasad, not a single new drug will be approved in US within the next few years. At best newer indications for ivermectin. We are better of with EMA and Swissmedic